Free Trial

Pharvaris (PHVS) Institutional Ownership

Pharvaris logo
$24.15
-0.72 (-2.90%)
(As of 11/1/2024 ET)

Institutional Ownership Changes (13F Filings) for Pharvaris (NASDAQ:PHVS)

Number of
Institutional Buyers
(last 12 months)
9
Total
Institutional Inflows
(last 12 months)
$69.74M
Number of
Institutional Sellers
(last 12 months)
7
Total
Institutional Outflows
(last 12 months)
$59.51M
Get PHVS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Pharvaris stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

PHVS Institutional Buying and Selling by Quarter

Pharvaris Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/20/2024 Novo Holdings A S1,725,000$32.43M1.6%+47.7%0.000%
8/15/2024Deerfield Management Company L.P. Series C1,397,279$26.27M0.4%+31.6%0.000%
8/14/2024Marshall Wace LLP51,168$962K0.0%-12.0%0.161%
8/10/2024Sofinnova Investments Inc.601,534$11.31M0.6%+2.9%1.889%
8/3/2024TD Asset Management Inc85,816$1.61M0.0%-23.8%0.000%
5/16/2024Bain Capital Life Sciences Investors LLC3,303,381$76.34M6.1%-15.4%0.000%
5/15/2024venBio Partners LLC4,289,304$99.13M35.2%-12.8%0.000%
5/15/2024Price T Rowe Associates Inc. MD757,915$17.52M0.0%-10.1%0.000%
2/15/2024Blackstone Inc.100,000$2.81M0.0%N/A0.314%
2/14/2024venBio Partners LLC4,919,504$137.99M20.7%+15.4%15.451%
2/14/2024Commodore Capital LP800,000$22.44M2.0%N/A2.513%
2/13/2024Bain Capital Life Sciences Investors LLC3,904,319$109.52M10.5%-18.4%0.000%
2/7/2024Vivo Capital LLC285,000$7.99M0.7%N/A0.000%
12/7/2023Hudson Bay Capital Management LP38,893$812K0.0%N/A0.122%
11/21/2023Walleye Capital LLC81,017$1.69M0.0%+15.2%0.254%
11/13/2023Foresite Capital Management V LLC33,142$692K1.1%-2.9%0.000%
11/13/2023FMR LLC3,207,564$66.94M0.0%-5.3%0.000%
8/15/2023Silverarc Capital Management LLC200,000$3.03M0.9%-64.2%0.000%
8/15/2023Bain Capital Life Sciences Investors LLC4,868,784$73.71M7.6%+53.1%0.000%
8/14/2023Cormorant Asset Management LP973,614$14.74M0.8%+19.2%0.000%
8/11/2023VR Adviser LLC1,326,200$20.08M3.2%N/A0.000%
8/11/2023General Atlantic L.P.4,406,252$66.71M1.1%+82.1%0.000%
8/11/2023Foresite Capital Management IV LLC3,743,450$56.68M27.9%+15.3%0.000%
5/15/2023Sio Capital Management LLC228,385$1.84M0.9%-19.9%0.717%
11/14/2022Cormorant Asset Management LP1,207,500$9.26M0.6%+5.4%3.792%
11/14/2022Pictet Asset Management SA399,875$3.21M0.0%-13.6%1.256%
8/16/2022venBio Partners LLC2,301,451$50.86M14.5%-0.1%7.228%
8/16/2022Deerfield Management Company L.P. Series C1,190,343$26.31M0.5%-24.5%3.739%
8/9/2022Pictet Asset Management SA462,630$10.22M0.0%-14.0%1.453%
5/17/2022Eventide Asset Management LLC302,619$5.66M0.1%+23.6%0.950%
5/16/2022Deerfield Management Company L.P. Series C1,577,078$28.60M0.6%-0.3%4.953%
5/16/2022Viking Global Investors LP2,480,319$46.38M0.2%+1.0%7.790%
2/14/2022Deerfield Management Company L.P. Series C1,581,331$22.76M0.5%-1.7%4.966%
2/14/2022Suvretta Capital Management LLC827,540$11.91M0.2%N/A2.599%
2/14/2022DAFNA Capital Management LLC36,720$528K0.1%+4.7%0.115%
2/14/2022 Novo Holdings A S516,321$7.43M0.4%+23.2%1.622%
2/10/2022Pictet Asset Management SA540,811$8.56M0.0%-2.9%1.699%
11/16/2021VR Adviser LLC552,882$9.80M1.3%-38.8%1.736%
11/16/2021Millennium Management LLC157,753$2.72M0.0%-19.9%0.495%
11/15/2021Deerfield Management Company L.P. Series C1,608,471$28.52M0.6%+55.7%5.052%
625,000% Gain (Ad)

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

11/10/2021Goldman Sachs Group Inc.30,174$535K0.0%+8.6%0.095%
10/28/2021 Compagnie Lombard Odier SCmA16,670$287K0.0%+10.9%0.052%
8/17/2021Millennium Management LLC196,967$3.58M0.0%-14.7%0.619%
8/17/2021 Caas Capital Management LP13,479$251K0.0%-73.0%0.042%
8/16/2021Opaleye Management Inc.79,837$1.49M0.2%N/A0.251%
8/16/2021Goldman Sachs Group Inc.27,792$518K0.0%+13.8%0.087%
8/13/2021Geode Capital Management LLC18,643$338K0.0%+13.8%0.059%
8/13/2021FMR LLC3,258,217$59.20M0.0%+17.7%10.233%
8/12/2021JPMorgan Chase & Co.16,434$299K0.0%+18.5%0.052%
6/10/2021Perceptive Advisors LLC27,000$755K0.0%N/A0.085%
5/27/2021Davidson Kempner Capital Management LP3,500$98K0.0%N/A0.011%
5/19/2021venBio Partners LLC2,303,310$64.45M6.1%N/A7.234%
5/18/2021Millennium Management LLC230,900$6.48M0.0%N/A0.725%
5/18/2021Zimmer Partners LP15,000$420K0.0%N/A0.047%
5/18/2021Cormorant Asset Management LP864,143$23.81M0.5%N/A2.714%
5/18/2021Davidson Kempner Capital Management LP3,500$98K0.0%N/A0.011%
5/17/2021Viking Global Investors LP2,420,155$67.91M0.2%N/A7.601%
5/17/2021Deerfield Management Company L.P. Series C1,032,757$28.90M0.6%N/A3.244%
5/17/2021Perceptive Advisors LLC27,000$755K0.0%N/A0.085%
5/17/2021General Atlantic LLC2,420,155$67.72M0.8%N/A7.601%
5/17/2021 Caas Capital Management LP50,000$1.40M0.0%N/A0.157%
5/17/2021Pinz Capital Management LP22,650$634K0.2%N/A0.071%
5/17/2021 Novo Holdings A S50,000$1.40M0.1%N/A0.157%
5/17/2021Goldman Sachs Group Inc.24,428$683K0.0%N/A0.077%
5/13/2021Rokos Capital Management LLP2,500$68K0.0%N/A0.008%
5/12/2021Geode Capital Management LLC16,384$459K0.0%N/A0.051%
5/12/2021Ensign Peak Advisors Inc5,000$140K0.0%N/A0.016%
5/12/2021JPMorgan Chase & Co.13,874$389K0.0%N/A0.044%
5/7/2021BlackRock Inc.33,382$934K0.0%N/A0.105%
(Data available from 1/1/2016 forward)

PHVS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of PHVS shares?

During the previous two years, 22 institutional investors and hedge funds held shares of Pharvaris. The most heavily invested institutionals were venBio Partners LLC ($99.13M), Bain Capital Life Sciences Investors LLC ($76.34M), FMR LLC ($66.94M), General Atlantic L.P. ($66.71M), Foresite Capital Management IV LLC ($56.68M), Novo Holdings A S ($32.43M), and Deerfield Management Company L.P. Series C ($26.27M).Learn more on PHVS's institutional investors.

Which institutional investors have been buying Pharvaris stock?

Of the 14 institutional investors that purchased Pharvaris stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: General Atlantic L.P. ($1.99M), Bain Capital Life Sciences Investors LLC ($1.69M), VR Adviser LLC ($1.33M), Commodore Capital LP ($800K), venBio Partners LLC ($654.83K), Novo Holdings A S ($556.97K), and Foresite Capital Management IV LLC ($496.52K).

How much institutional buying is happening at Pharvaris?

Institutional investors have bought a total of 8,514,640 shares in the last 24 months. This purchase volume represents approximately $159.04M in transactions.

Which Pharvaris major shareholders have been selling company stock?

Of the 10 institutional investors that sold Pharvaris stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Bain Capital Life Sciences Investors LLC ($1.48M), venBio Partners LLC ($630.20K), Silverarc Capital Management LLC ($359.39K), FMR LLC ($179.59K), Price T Rowe Associates Inc. MD ($84.78K), Pictet Asset Management SA ($62.76K), and Sio Capital Management LLC ($56.62K).

How much institutional selling is happening at Pharvaris?

Institutional investors have sold a total of 2,889,427 shares in the last 24 months. This volume of shares sold represents approximately $66.09M in transactions.



This page (NASDAQ:PHVS) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners